Oral cancer and associated risk factors

Prevention in Clinical Oral Health Care

Volumn , Issue , 2008, Pages 68-77

  Jones, Daniel L ^a   Rankin, K Vendrell ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882520331     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03695-5.50010-0     Document Type: Chapter

References (82)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005, 55:1. 11-30.
2. Ries LAG, Eisner MP, Kosary CL et al., editors: SEER Cancer Statistics Review, 1975-2000.
3. Silverman S Leukoplakia and erythroplasia. Oral cancer 1998, B. C. Decker, Hamilton (Canada).
4. Califano J, van der Reit P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488-2492.
5. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996, 56:3630-3633.
6. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996, 2:682-685.
7. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000, 6:1702-1710.
8. Partridge M, Pateromichelakis S, Phillips E, et al. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 2000, 60:3893-3898.
9. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000, 6:357-362.
10. Lazarus P, Garewal HS, Sciubba J, et al. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. Int J Cancer 1995, 60:458-463.
11. Brennan JA, Boyle JO, Koch WM et al.: Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck, N Engl J Med 332:712-717.
12. Koch WM, Lango M, Sewell D, et al. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999, 109:1544-1551.
13. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch: Surveillance, Epidemiology, and End Results (SEER) Program SEER Stat Database Incidence-SEER 13 Regs Public-Use, Nov 2004 Sub (1973-2002 varying) (website):, released April 2005, based on the November 2004 submission. http://www.seer.cancer.gov.
14. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch: Surveillance, Epidemiology, and End Results (SEER) Program DevCan database: "SEER 12 Incidence and Mortality, 1997-2001, Follow-back year=1992" (website):, released October 2004, based on the November 2003 submission. Underlying mortality data provided by NCHS ( ). http://www.cdc.gov/nchs.
15. Women and smoking: a report of the Surgeon General 2001, U.S. Department of Health and Human Services, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
16. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002, 51:300-303. Centers for Disease Control and Prevention.
17. Health United States, 2003 with chartbook on trends in the health of Americans 2003, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, Md.
18. McGinnis J, Foege WH Actual causes of death in United States. JAMA 1993, 270:2207-2212.
19. U.S. Department of Health and Human Services: Reducing the health consequences of smoking-25 years of progress: a report of the Surgeon General, Atlanta, Ga, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1989, DHHS Pub. No. (CDC) 89-8411.
20. The health consequences of using smokeless tobacco: a report of the Advisory Committee to the Surgeon General 1986, U.S. Department of Health and Human Services, U.S. Department of Health and Human Services, Public Health Service, Bethesda, Md, NIH Pub. No. 86-2874.
21. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service 1964, U.S. Department of Health, Education, and Welfare, U.S. Department of Health, Education, and Welfare. Public Health Service, Washington, DC, PHS Publication 1103.
22. U.S. Department of Health and Human Services: The health consequences of smoking: a report of the Surgeon General, Atlanta, GA, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Washington, DC, 2004.
23. Franceschi S, Barra S, La Vecchia C, et al. Risk factors for cancer of the tongue and the mouth: a case-control study from northern Italy. Cancer 1992, 70:2227-2233.
24. McLaughlin JK, Hrubec Z, Blot WJ, et al. Smoking and cancer mortality among U.S. veterans: a 26-year follow-up. Int J Cancer 1995, 60:190-193.
25. Muscat JE, Richie JP, Thompson S, et al. Gender differences in smoking and risk for oral cancer. Cancer Res 1996, 56:5192-5197.
26. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine, Smoking and Tobacco Control Monograph 13 2001, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Md, NIH Pub. No. 02-5974.
27. Reducing tobacco use: a report of the Surgeon General 2000, U.S. Department of Health and Human Services, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
28. Clearing the smoke: assessing the science base for tobacco harm prevention 2001, Institute of Medicine, National Academy Press, Washington, DC.
29. Bidi use among urban youth-Massachusetts, March-April 1999. MMWR Morb Mortal Wkly Rep 1999, 48:796-799. Centers for Disease Control and Prevention.
30. Yen KL, Hechavarria E, Bostwick SB Bidi cigarettes: an emerging threat to adolescent health. Arch Pediatr Adolesc Med 2000, 154:1187-1189.
31. Watson CH, Polzin GM, Calafat AM, et al. Determination of the tar, nicotine, and carbon monoxide yields in the smoke of bidi cigarettes. Nicotine Tob Res 2003, 5:747-753.
32. Rahman M, Sakamoto J, Fukui T Bidi smoking and oral cancer: a meta-analysis. Int J Cancer 2003, 106:600-604.
33. Malson JL, Lee EM, Murty R, et al. Clove cigarette smoking: biochemical, physiological, and subjective effects. Pharmacol Biochem Behav 2003, 74:739-745.
34. Evaluation of the health hazard of clove cigarettes. JAMA 1988, 260:3641-3644. Council on Scientific Affairs.
35. Rahman M, Fukui T Bidi smoking and health. Public Health 2000, 114:123-127.
36. Clemmesen JC Statistical studies in the aetiology of malignant neoplasms 1965, vol 1. Copenhagen, Munksgaard.
37. Levin ML, Goldstein H, Gerhardt PR Cancer and tobacco smoking. JAMA 1950, 143:336.
38. Wynder EL, Bross IJ, Feldman RM A study of the etiological factors in cancer of the mouth. Cancer 1957, 10:1300.
39. Spitzer WO, Hill GB, Chambers LW, et al. The occupation of fishing as a risk factor in cancer of the lip. N Engl J Med 1975, 293:419.
40. Henley SJ, Thun MJ, Chao A, et al. Association between exclusive pipe smoking and mortality from cancer and other diseases. J Natl Cancer Inst 2004, 96:853-861.
41. Shafagoj YA, Mohammed FI, Hadidi K Hubble-bubble (water pipe) smoking: levels of nicotine and cotinine in plasma, saliva and urine. Int J Clin Pharmacol Ther 2002, 40:249-255.
42. Knishkowy B, Amitai Y Water-pipe (narghile) smoking: an emerging health risk behavior. Pediatrics 2005, 116:113-119.
43. Maziak W, Ward KD, Afifi Soweid RA, et al. Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tob Control 2004, 13:327-333.
44. Kulwicki A, Rice VH Arab American adolescent perceptions and experiences with smoking. Public Health Nurs 2003, 20:177-183.
45. Cigars: health effects and trends, Smoking and Tobacco Control Monograph No. 9 1998, National Cancer Institute, National Institutes of Health, National Cancer Institute, Bethesda, MD, NIH Pub. No. 98-4302.
46. Baker F, Ainsworth SR, Dye J, et al. Health risks associated with cigar smoking. JAMA 2000, 284:735-740.
47. Results from 2003 national survey on drug use and health: national findings 2004, Substance Abuse and Mental Health Services Administration, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, Md.
48. The health consequences of smoking: cancer. A report of the Surgeon General 1982, U.S. Department of Health and Human Services, U.S. Department of Health and Human Services, Public Health Service, Rockville, Md.
49. Shapiro JA, Jacobs EJ, Thun MJ Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst 2000, 92:333-337.
50. Hatsukami DK, Severson HH Oral spit tobacco: addiction, prevention and treatment. Nicotine Tob Res 1991, 1:21-44.
51. Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products-Florida, January-February 1999. MMWR Morb Mortal Wkly Rep 1999, 48:398-401. Centers for Disease Control and Prevention.
52. National Institutes of Health: Health implications of smokeless tobacco use (1986), NIH consensus statement online:. http://consensus.nih.gov/cons/053/053_statement.htm.
53. Winn DM, Blot WJ, Shy CM, et al. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981, 304:745-749.
54. Summaries & Evaluations Tobacco habits other than smoking 1985, Vol 37. International Agency for Research on Cancer (IARC).
55. Martin GC, Brown JP, Eifler CW, et al. Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc 1999, 130:945-954.
56. Moore C Smoking and cancer of the mouth, pharynx, and larynx. JAMA 1965, 25(191):283-286.
57. Bouquot JE Oral leukoplakia and erythroplakia: a review and update. Pract Periodont Aesthet Dent 1994, 6:9-17.
58. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years: observations on male British doctors. BMJ 1994, 309:901-911.
59. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000, 321:323-329.
60. The health benefits of smoking cessation: report of the Surgeon General 1990, U.S. Department of Health and Human Services, U.S. Department for Health and Human Services, Rockville, Md.
61. Mashberg A, Garfinkel L, Harris S Alcohol as a primary risk factor in oral squamous cell carcinoma. CA Cancer J Clin 1981, 31:146-155.
62. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997, 337:1705-1714.
63. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48:3282-3287.
64. Thomson PJ, Potten CS, Appleton DR Characterization of epithelial cell activity in patients with oral cancer. Br J Oral Maxillofac Surg 1999, 37:384-390.
65. Huber MA, Terezhalmy GT The patient with actinic cheilosis. Gen Dent 2006, 54:274-282.
66. Gatti RA, Good RA Occurrence of malignancy in immunedeficiency disease. Cancer 1971, 28:89.
67. Kersey JH, Spector BD, Good RA Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer 1973, 12:333.
68. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720.
69. Miller CS, Johnstone BM Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:622-635.
70. Park K, Cherrick HM, Min BM, et al. Active HSV-1 immunization prevents the cocarcinogenic activity of HSV-1 in the oral cavity of hamsters. Oral Surg Oral Med Oral Pathol 1990, 70:186-191.
71. Maserejian NN, Giovannucci E, Rosner B, et al. Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men. Int J Cancer 2006, 120:970-977.
72. Stevens RG, Jones DY, Micozzi MS, et al. Body iron stores and the risk of cancer. N Engl J Med 1988, 319:1047-1052.
73. Silverman S, Gorsky M, Lozada-Nur F, et al. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991, 72:665-670.
74. Chainani-Wu N, Silverman S, Lozada-Nur F, et al. Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc 2001, 132:901-909.
75. Barnard NA, Scully C, Everson JAW Oral cancer development in patients with oral lichen planus. J Oral Pathol Med 1993, 22:421-424.
76. Christian DC Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. J Am Dent Assoc 2002, 133:357-362.
77. Mashberg A, Samit A Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995, 45:328-351.
78. Portugal LC, Wilson KM, Biddinger PW, et al. The role of toluidine blue in assessing margin status after resection of squamous cell carcinomas of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1996, 122:517-519.
79. Warnakulasuriya KAAS, John NW Sensitivity and specificity of Orascan toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 1996, 25:91-110.
80. Dolan TA, McGorray SP, Grinstead-Skigen CL, et al. Tobacco control activities in U.S. dental practices. J Am Dent Assoc 1997, 128:1669-1679.
81. Secker-Walker RH, Solomon LJ, Flynn BS, et al. Comparisons of the smoking cessation counseling activities of six types of health professionals. Prev Med 1994, 23:800-808.
82. Albert D, Ward A, Ahluwalia K, et al. Addressing tobacco in managed care: a survey of dentists' knowledge, attitudes, and behaviors. Am J Public Health 2002, 92:997-1001.